ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-"Yes".

Leoni Rolfes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.